/RYLPF

RYLPF Stock - Koninklijke Philips N.V.

Q: What is the analyst price target for RYLPF?

Analyst price target information is not currently available for RYLPF.

Q: What is RYLPF's market cap?

Market capitalization information is not currently available for RYLPF.

Healthcare|Medical - Devices|OTC

$25.93+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $28.52

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RYLPF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.91

52W High$28.42

52W Low$21.27

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$18.02B	$18.17B	$17.83B	$17.16B	$19.54B
Gross Profit	$7.77B	$7.45B	$7.19B	$7.17B	$8.78B
Gross Margin	43.1%	41.0%	40.4%	41.8%	45.0%
Operating Income	$529.00M	$-115,000,000	$-1,529,000,000	$553.00M	$1.54B
Net Income	$-702,000,000	$-466,000,000	$-1,608,000,000	$3.32B	$1.19B
Net Margin	-3.9%	-2.6%	-9.0%	19.3%	6.1%
EPS	$-0.75	$-0.50	$-1.68	$3.51	$1.25

Company Overview

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Visit Website

Earnings History & Surprises

RYLPF

Beat Rate

13%

Last 16 quarters

Avg Surprise

-98.5%

EPS vs Estimate

Beats / Misses

2/13

1 met exactly

Latest EPS

$0.22

Q4 2025

EPS Surprise History

Q1 24

-91.8%

$0.05vs$0.56

Q2 24

-496.8%

$-1.15vs$0.29

Q3 24

No data

Q4 24

-50.9%

$0.21vs$0.43

Q1 25

No data

Q2 25

-60.8%

$0.08vs$0.21

Q3 25

-6.6%

$0.30vs$0.32

Q4 25

-38.8%

$0.22vs$0.37

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 4, 2026	—	—	—	—
Q1 2026	Jan 28, 2026	—	—	—	—
Q4 2025	Nov 4, 2025	$0.37	$0.22	-38.8%	✗ MISS
Q3 2025	Jul 29, 2025	$0.32	$0.30	-6.6%	✗ MISS
Q2 2025	May 6, 2025	$0.21	$0.08	-60.8%	✗ MISS
Q1 2025	Feb 19, 2025	—	$-0.37	—	—
Q4 2024	Oct 28, 2024	$0.43	$0.21	-50.9%	✗ MISS
Q3 2024	Jul 29, 2024	—	$0.54	—	—
Q2 2024	Apr 29, 2024	$0.29	$-1.15	-496.8%	✗ MISS
Q1 2024	Mar 12, 2024	$0.56	$0.05	-91.8%	✗ MISS
Q3 2023	Sep 30, 2023	$0.30	$0.10	-66.8%	✗ MISS
Q2 2023	Jun 30, 2023	$0.28	$0.08	-70.2%	✗ MISS
Q1 2023	Mar 31, 2023	$0.13	$-0.79	-702.1%	✗ MISS
Q1 2023	Jan 30, 2023	$0.16	$0.41	+156.2%	✓ BEAT
Q4 2022	Oct 24, 2022	$0.34	$0.25	-26.5%	✗ MISS
Q3 2022	Jul 25, 2022	$0.28	$0.14	-50.0%	✗ MISS
Q2 2022	Apr 25, 2022	$0.25	$0.15	-40.0%	✗ MISS
Q1 2022	Jan 24, 2022	$0.86	$0.57	-33.7%	✗ MISS
Q4 2021	Oct 18, 2021	$0.40	$0.40	0.0%	= MET
Q3 2021	Jul 26, 2021	$0.39	$0.40	+2.6%	✓ BEAT

Frequently Asked Questions about RYLPF

What is RYLPF's current stock price?

Koninklijke Philips N.V. (RYLPF) is currently trading at $25.93 per share. The stock has moved +0.00% today.

What is the analyst price target for RYLPF?

No analyst price targets are currently available for this stock.

What sector is Koninklijke Philips N.V. in?

Koninklijke Philips N.V. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is RYLPF's market cap?

Koninklijke Philips N.V. has a market capitalization of $24.65 billion, making it a large-cap company.

Does RYLPF pay dividends?

No, Koninklijke Philips N.V. does not currently pay a dividend to shareholders.